Fabbio Patrick has filed 11 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 22165 shares of BeyondSpring Inc. ($BYSI) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | BeyondSpring Inc. | $BYSI | Fabbio Patrick | Not found | A | Stock Options (right to buy) | 22165 | $0.00 | 22,165.0000 | 40,332,320 | 9999.99% | 0.05% |
| Jan. 26, 2026 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | F | Common Stock | 3261 | $6.67 | 64,115.0000 | 42,272,104 | 4.84% | 0.01% |
| Jan. 20, 2026 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | F | Common Stock | 3063 | $5.60 | 67,376.0000 | 42,272,104 | 4.35% | 0.01% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | A | Common Stock | 28000 | $0.00 | 70,439.0000 | 42,272,104 | 65.98% | 0.07% |
| Jan. 16, 2026 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 42,272,104 | 9999.99% | 0.41% |
| April 21, 2025 | BeyondSpring Inc. | $BYSI | Fabbio Patrick | Not found | A | Stock Options (right to buy) | 23793 | $0.00 | 23,793.0000 | 40,316,320 | 9999.99% | 0.06% |
| Jan. 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 20,592,847 | 9999.99% | 0.68% |
| Jan. 24, 2025 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | A | Common Stock | 23500 | $0.00 | 45,500.0000 | 20,592,847 | 106.82% | 0.11% |
| Jan. 21, 2025 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | F | Common Stock | 3061 | $4.76 | 18,939.0000 | 20,592,847 | 13.91% | 0.01% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | A | Stock Option (Right to Buy) | 131000 | $0.00 | 131,000.0000 | 11,331,338 | 9999.99% | 1.16% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Fabbio Patrick | Chief Financial Officer | A | Common Stock | 22000 | $0.00 | 22,000.0000 | 11,331,338 | 9999.99% | 0.19% |